Luca R.
- Country
- Italy
- Department
- U.O.C. Pneumologia
Research Overview
- Efficacy and Safety of BI 1015550 in Individuals with Interstitial Lung Abnormalities and a Family History of Pulmonary Fibrosis: A Randomized, Placebo-Controlled Trial
- A study to evaluate the safety and effectiveness of inhaled nintedanib in patients with idiopathic pulmonary fibrosis
- A Phase IIb, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Zampilimab in Participants with Idiopathic Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 272 of 511 partner sites.
Specializations
Pulmonary Fibrosis Research
Primary investigator focusing on various forms of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Specializes in evaluating novel therapeutic approaches for managing fibrotic lung conditions.
- Lung Function Assessment
- Fibrosis Disease Progression
- Chronic Cough Management
Investigates both oral and inhaled therapeutic interventions for fibrotic lung diseases.
Respiratory Disease Management
Experienced in treating complex respiratory conditions including severe asthma and chronic obstructive pulmonary disease (COPD). Focuses on innovative treatment approaches for patients with inadequate response to standard therapies.
- Severe Asthma Control
- COPD Exacerbation Prevention
- Respiratory Function Optimization
Specializes in evaluating combination therapies and novel biological treatments.
Specialized Pulmonary Conditions
Conducts research on distinct respiratory disorders including pulmonary sarcoidosis and nontuberculous mycobacterial lung infections. Focuses on developing targeted therapeutic approaches.
- Mycobacterial Infection Treatment
- Sarcoidosis Management
- Interstitial Lung Disease Therapy
Explores innovative treatment modalities for rare and complex pulmonary conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.